Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices_老虎社区_美港股上老虎

Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices

Oilprice.com2021-08-25

The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

190

小虎和小孩
·2021-08-25
interesting
回复
1
举报
GodSpeed
·2021-08-25
Pls like
回复
点赞
举报
chongyeetan
·2021-08-25
pls like. 👍
回复
点赞
举报
Cash88
·2021-08-25
Drop more...
回复
2
举报
收起
- ramius75:
  Yeah man
  2021-08-25
  回复
  举报
心球队长
·2021-08-25
Comment
回复
2
举报
Dave Fu
·2021-08-25
Steady
回复
点赞
举报
收起
- GodSpeed:
  pompepe
  2021-08-25
  回复
  举报
Wallstrtbets
·2021-08-25
Boon yh.
回复
1
举报
收起
- 心球队长:
  Comment
  2021-08-25
  回复
  举报
小白添祥
·2021-08-25
like & comment please, thank you very much
回复
4
举报
收起
- 1f7a6fad:
  Like
  2021-08-25
  回复
  举报
nelson21
·2021-08-25
Pls like and comment
回复
5
举报
收起
- 小白添祥:
  like & comment please, thank you very much
  2021-08-25
  回复
  举报
关耳火丙光军
·2021-08-25
Share of Pfizer will shoot up further...........! Buy
回复
6
举报
收起
- 小白添祥:
  like & comment please, thank you very much
  2021-08-25
  回复
  举报
- 500k:
  why approved share price down ??
  2021-08-25
  回复
  举报
Eatmi
·2021-08-25
like
回复
3
举报
收起
- 小白添祥:
  like & comment please, thank you very much
  2021-08-25
  回复
  举报
KTX
·2021-08-25
Like
回复
1
举报
Darylzhuo
·2021-08-25
Please like and comment. Thank you
回复
2
举报
收起
- Eatmi:
  ok
  2021-08-25
  回复
  举报
Al3x
·2021-08-25
like
回复
4
举报
收起
- 豪仔9:
  Done
  2021-08-25
  回复
  举报
FrederickL
·2021-08-25
Becos the material requirements to make it? 🤔
回复
4
举报
5949571c
·2021-08-25
Like
回复
5
举报
收起
- Al3x:
  like
  2021-08-25
  回复
  举报
Ignis
·2021-08-25
Dotn know don't care
回复
5
举报
收起
- 5949571c:
  Ok
  2021-08-25
  回复
  举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2162038191?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-08-25 09:05","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2162038191","market":"us","top_or_hot":-1,"title":"Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices","media":"Oilprice.com","content":"<div>\n<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html\">网页链接</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer’s FDA Approval Has Been A Boon For Oil Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 09:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html><strong>Oilprice.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html","article_id":"2162038191","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2162038191","pubTimestamp":1629853500,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in o","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"PFE":"辉瑞"},"translate_title":"为什么辉瑞食品和药物管理局的批准对油价有利","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":0.9},"content_text":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.\nPerhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.\nIn further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.\nA weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.\nThis slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.\nLast week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.\nThe second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.\nWhen this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is one possible solution, but availability may be limited in most parts of the world.\nOn the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.\n\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.\nMeanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.\n\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market commentary on Monday.\nRecent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":837140436,"gmtCreate":1629867689625,"gmtModify":1631885407933,"author":{"id":"3582713177188935","authorId":"3582713177188935","authorIdStr":"3582713177188935","name":"小虎和小孩","avatar":"https://static.tigerbbs.com/059621c51ba25b6a865b0278e6b8b9cb","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582713177188935"},"htmlText":"interesting","listText":"interesting","text":"interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/837140436","repostId":2162038191,"repostType":2,"repost":{"id":"2162038191","pubTimestamp":1629853500,"share":"https://www.laohu8.com/m/news/2162038191?lang=&edition=full","pubTime":"2021-08-25 09:05","market":"us","language":"en","title":"Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2162038191","media":"Oilprice.com","summary":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in o","content":"<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.</p>\n<p>Perhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.</p>\n<p>In further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.</p>\n<p>A weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.</p>\n<p>This slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.</p>\n<p>Last week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.</p>\n<p>The second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.</p>\n<p>When this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is <a href=\"https://laohu8.com/S/AONE.U\">one</a> possible solution, but availability may be limited in most parts of the world.</p>\n<p>On the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.</p>\n<p>\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.</p>\n<p>Meanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.</p>\n<p>\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market&nbsp;commentary&nbsp;on Monday.</p>\n<p>Recent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer’s FDA Approval Has Been A Boon For Oil Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 09:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html><strong>Oilprice.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162038191","content_text":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.\nPerhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.\nIn further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.\nA weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.\nThis slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.\nLast week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.\nThe second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.\nWhen this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is one possible solution, but availability may be limited in most parts of the world.\nOn the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.\n\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.\nMeanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.\n\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market commentary on Monday.\nRecent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":837153992,"gmtCreate":1629866914916,"gmtModify":1631889891315,"author":{"id":"3555741898245131","authorId":"3555741898245131","authorIdStr":"3555741898245131","name":"GodSpeed","avatar":"https://static.tigerbbs.com/ee5f7232b69fab8a90a42644f3305575","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3555741898245131"},"htmlText":"Pls like&nbsp;","listText":"Pls like&nbsp;","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/837153992","repostId":2162038191,"repostType":4,"repost":{"id":"2162038191","pubTimestamp":1629853500,"share":"https://www.laohu8.com/m/news/2162038191?lang=&edition=full","pubTime":"2021-08-25 09:05","market":"us","language":"en","title":"Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2162038191","media":"Oilprice.com","summary":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in o","content":"<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.</p>\n<p>Perhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.</p>\n<p>In further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.</p>\n<p>A weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.</p>\n<p>This slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.</p>\n<p>Last week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.</p>\n<p>The second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.</p>\n<p>When this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is <a href=\"https://laohu8.com/S/AONE.U\">one</a> possible solution, but availability may be limited in most parts of the world.</p>\n<p>On the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.</p>\n<p>\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.</p>\n<p>Meanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.</p>\n<p>\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market&nbsp;commentary&nbsp;on Monday.</p>\n<p>Recent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer’s FDA Approval Has Been A Boon For Oil Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 09:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html><strong>Oilprice.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162038191","content_text":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.\nPerhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.\nIn further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.\nA weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.\nThis slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.\nLast week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.\nThe second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.\nWhen this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is one possible solution, but availability may be limited in most parts of the world.\nOn the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.\n\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.\nMeanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.\n\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market commentary on Monday.\nRecent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":837385867,"gmtCreate":1629857476359,"gmtModify":1631893982213,"author":{"id":"3573519539005968","authorId":"3573519539005968","authorIdStr":"3573519539005968","name":"chongyeetan","avatar":"https://static.tigerbbs.com/58f6eb6730af7768ad82093944f2351a","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3573519539005968"},"htmlText":"pls like. 👍","listText":"pls like. 👍","text":"pls like. 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/837385867","repostId":2162038191,"repostType":4,"repost":{"id":"2162038191","pubTimestamp":1629853500,"share":"https://www.laohu8.com/m/news/2162038191?lang=&edition=full","pubTime":"2021-08-25 09:05","market":"us","language":"en","title":"Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2162038191","media":"Oilprice.com","summary":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in o","content":"<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.</p>\n<p>Perhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.</p>\n<p>In further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.</p>\n<p>A weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.</p>\n<p>This slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.</p>\n<p>Last week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.</p>\n<p>The second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.</p>\n<p>When this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is <a href=\"https://laohu8.com/S/AONE.U\">one</a> possible solution, but availability may be limited in most parts of the world.</p>\n<p>On the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.</p>\n<p>\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.</p>\n<p>Meanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.</p>\n<p>\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market&nbsp;commentary&nbsp;on Monday.</p>\n<p>Recent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer’s FDA Approval Has Been A Boon For Oil Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 09:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html><strong>Oilprice.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162038191","content_text":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.\nPerhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.\nIn further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.\nA weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.\nThis slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.\nLast week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.\nThe second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.\nWhen this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is one possible solution, but availability may be limited in most parts of the world.\nOn the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.\n\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.\nMeanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.\n\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market commentary on Monday.\nRecent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":837314872,"gmtCreate":1629857066996,"gmtModify":1631891723338,"author":{"id":"3586517695826971","authorId":"3586517695826971","authorIdStr":"3586517695826971","name":"Cash88","avatar":"https://static.tigerbbs.com/65a02861482d3cada99b9d8f8b4b76eb","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586517695826971"},"htmlText":"Drop more...&nbsp;","listText":"Drop more...&nbsp;","text":"Drop more...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/837314872","repostId":2162038191,"repostType":4,"repost":{"id":"2162038191","pubTimestamp":1629853500,"share":"https://www.laohu8.com/m/news/2162038191?lang=&edition=full","pubTime":"2021-08-25 09:05","market":"us","language":"en","title":"Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2162038191","media":"Oilprice.com","summary":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in o","content":"<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.</p>\n<p>Perhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.</p>\n<p>In further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.</p>\n<p>A weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.</p>\n<p>This slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.</p>\n<p>Last week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.</p>\n<p>The second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.</p>\n<p>When this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is <a href=\"https://laohu8.com/S/AONE.U\">one</a> possible solution, but availability may be limited in most parts of the world.</p>\n<p>On the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.</p>\n<p>\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.</p>\n<p>Meanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.</p>\n<p>\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market&nbsp;commentary&nbsp;on Monday.</p>\n<p>Recent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer’s FDA Approval Has Been A Boon For Oil Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 09:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html><strong>Oilprice.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162038191","content_text":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.\nPerhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.\nIn further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.\nA weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.\nThis slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.\nLast week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.\nThe second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.\nWhen this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is one possible solution, but availability may be limited in most parts of the world.\nOn the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.\n\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.\nMeanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.\n\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market commentary on Monday.\nRecent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5640360,"gmtCreate":1629857388915,"gmtModify":1635143153945,"authorId":3586470645934044,"author":{"id":3586470645934044,"authorId":3586470645934044,"name":"ramius75","avatar":"https://static.tigerbbs.com/10763970a5bf5e3128c5423ebbee8096","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":837314872,"type":1,"supId":0,"prevId":0,"content":"Yeah man","text":"Yeah man","html":"Yeah man"}],"langContent":"EN"},{"id":837312401,"gmtCreate":1629856988703,"gmtModify":1633681906421,"author":{"id":"3578543471370104","authorId":"3578543471370104","authorIdStr":"3578543471370104","name":"心球队长","avatar":"https://static.tigerbbs.com/e854666fe16cc40b3c5446dd51838f7e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3578543471370104"},"htmlText":"Comment&nbsp;","listText":"Comment&nbsp;","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/837312401","repostId":2162038191,"repostType":4,"repost":{"id":"2162038191","pubTimestamp":1629853500,"share":"https://www.laohu8.com/m/news/2162038191?lang=&edition=full","pubTime":"2021-08-25 09:05","market":"us","language":"en","title":"Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2162038191","media":"Oilprice.com","summary":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in o","content":"<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.</p>\n<p>Perhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.</p>\n<p>In further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.</p>\n<p>A weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.</p>\n<p>This slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.</p>\n<p>Last week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.</p>\n<p>The second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.</p>\n<p>When this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is <a href=\"https://laohu8.com/S/AONE.U\">one</a> possible solution, but availability may be limited in most parts of the world.</p>\n<p>On the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.</p>\n<p>\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.</p>\n<p>Meanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.</p>\n<p>\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market&nbsp;commentary&nbsp;on Monday.</p>\n<p>Recent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer’s FDA Approval Has Been A Boon For Oil Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 09:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html><strong>Oilprice.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162038191","content_text":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.\nPerhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.\nIn further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.\nA weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.\nThis slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.\nLast week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.\nThe second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.\nWhen this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is one possible solution, but availability may be limited in most parts of the world.\nOn the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.\n\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.\nMeanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.\n\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market commentary on Monday.\nRecent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":837337778,"gmtCreate":1629856661094,"gmtModify":1633681910930,"author":{"id":"3582630305022272","authorId":"3582630305022272","authorIdStr":"3582630305022272","name":"Dave Fu","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":7,"crmLevelSwitch":0,"idStr":"3582630305022272"},"htmlText":"Steady","listText":"Steady","text":"Steady","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/837337778","repostId":2162038191,"repostType":4,"repost":{"id":"2162038191","pubTimestamp":1629853500,"share":"https://www.laohu8.com/m/news/2162038191?lang=&edition=full","pubTime":"2021-08-25 09:05","market":"us","language":"en","title":"Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2162038191","media":"Oilprice.com","summary":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in o","content":"<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.</p>\n<p>Perhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.</p>\n<p>In further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.</p>\n<p>A weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.</p>\n<p>This slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.</p>\n<p>Last week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.</p>\n<p>The second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.</p>\n<p>When this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is <a href=\"https://laohu8.com/S/AONE.U\">one</a> possible solution, but availability may be limited in most parts of the world.</p>\n<p>On the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.</p>\n<p>\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.</p>\n<p>Meanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.</p>\n<p>\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market&nbsp;commentary&nbsp;on Monday.</p>\n<p>Recent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer’s FDA Approval Has Been A Boon For Oil Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 09:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html><strong>Oilprice.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162038191","content_text":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.\nPerhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.\nIn further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.\nA weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.\nThis slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.\nLast week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.\nThe second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.\nWhen this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is one possible solution, but availability may be limited in most parts of the world.\nOn the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.\n\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.\nMeanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.\n\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market commentary on Monday.\nRecent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5641946,"gmtCreate":1629866923000,"gmtModify":1635143042835,"authorId":3555741898245131,"author":{"id":3555741898245131,"authorId":3555741898245131,"name":"GodSpeed","avatar":"https://static.tigerbbs.com/ee5f7232b69fab8a90a42644f3305575","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":837337778,"type":1,"supId":0,"prevId":0,"content":"pompepe","text":"pompepe","html":"pompepe"}],"langContent":"EN"},{"id":837394477,"gmtCreate":1629856046199,"gmtModify":1633681919208,"author":{"id":"3566244878628904","authorId":"3566244878628904","authorIdStr":"3566244878628904","name":"Wallstrtbets","avatar":"https://static.tigerbbs.com/6c38bbee1121ea92508ad9508fa15c5e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3566244878628904"},"htmlText":"Boon yh.","listText":"Boon yh.","text":"Boon yh.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/837394477","repostId":2162038191,"repostType":4,"repost":{"id":"2162038191","pubTimestamp":1629853500,"share":"https://www.laohu8.com/m/news/2162038191?lang=&edition=full","pubTime":"2021-08-25 09:05","market":"us","language":"en","title":"Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2162038191","media":"Oilprice.com","summary":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in o","content":"<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.</p>\n<p>Perhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.</p>\n<p>In further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.</p>\n<p>A weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.</p>\n<p>This slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.</p>\n<p>Last week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.</p>\n<p>The second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.</p>\n<p>When this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is <a href=\"https://laohu8.com/S/AONE.U\">one</a> possible solution, but availability may be limited in most parts of the world.</p>\n<p>On the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.</p>\n<p>\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.</p>\n<p>Meanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.</p>\n<p>\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market&nbsp;commentary&nbsp;on Monday.</p>\n<p>Recent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer’s FDA Approval Has Been A Boon For Oil Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 09:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html><strong>Oilprice.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162038191","content_text":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.\nPerhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.\nIn further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.\nA weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.\nThis slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.\nLast week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.\nThe second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.\nWhen this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is one possible solution, but availability may be limited in most parts of the world.\nOn the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.\n\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.\nMeanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.\n\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market commentary on Monday.\nRecent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5640281,"gmtCreate":1629856983778,"gmtModify":1635143160108,"authorId":3578543471370104,"author":{"id":3578543471370104,"authorId":3578543471370104,"name":"心球队长","avatar":"https://static.tigerbbs.com/e854666fe16cc40b3c5446dd51838f7e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":837394477,"type":1,"supId":0,"prevId":0,"content":"Comment ","text":"Comment ","html":"Comment "}],"langContent":"EN"},{"id":837398341,"gmtCreate":1629855807183,"gmtModify":1633681922664,"author":{"id":"3571345352614779","authorId":"3571345352614779","authorIdStr":"3571345352614779","name":"小白添祥","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3571345352614779"},"htmlText":"like &amp; comment please, thank you very much&nbsp;","listText":"like &amp; comment please, thank you very much&nbsp;","text":"like & comment please, thank you very much","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/837398341","repostId":2162038191,"repostType":4,"repost":{"id":"2162038191","pubTimestamp":1629853500,"share":"https://www.laohu8.com/m/news/2162038191?lang=&edition=full","pubTime":"2021-08-25 09:05","market":"us","language":"en","title":"Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2162038191","media":"Oilprice.com","summary":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in o","content":"<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.</p>\n<p>Perhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.</p>\n<p>In further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.</p>\n<p>A weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.</p>\n<p>This slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.</p>\n<p>Last week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.</p>\n<p>The second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.</p>\n<p>When this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is <a href=\"https://laohu8.com/S/AONE.U\">one</a> possible solution, but availability may be limited in most parts of the world.</p>\n<p>On the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.</p>\n<p>\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.</p>\n<p>Meanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.</p>\n<p>\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market&nbsp;commentary&nbsp;on Monday.</p>\n<p>Recent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer’s FDA Approval Has Been A Boon For Oil Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 09:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html><strong>Oilprice.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162038191","content_text":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.\nPerhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.\nIn further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.\nA weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.\nThis slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.\nLast week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.\nThe second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.\nWhen this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is one possible solution, but availability may be limited in most parts of the world.\nOn the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.\n\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.\nMeanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.\n\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market commentary on Monday.\nRecent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5640267,"gmtCreate":1629856932390,"gmtModify":1635143161277,"authorId":4088296712073280,"author":{"id":4088296712073280,"authorId":4088296712073280,"name":"1f7a6fad","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":837398341,"type":1,"supId":0,"prevId":0,"content":"Like ","text":"Like ","html":"Like "}],"langContent":"EN"},{"id":837302465,"gmtCreate":1629855413157,"gmtModify":1633681927836,"author":{"id":"3581678664547146","authorId":"3581678664547146","authorIdStr":"3581678664547146","name":"nelson21","avatar":"https://static.tigerbbs.com/f3bfb16048c75dbf023d98c18914333e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581678664547146"},"htmlText":"Pls like and comment","listText":"Pls like and comment","text":"Pls like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/837302465","repostId":2162038191,"repostType":4,"repost":{"id":"2162038191","pubTimestamp":1629853500,"share":"https://www.laohu8.com/m/news/2162038191?lang=&edition=full","pubTime":"2021-08-25 09:05","market":"us","language":"en","title":"Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2162038191","media":"Oilprice.com","summary":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in o","content":"<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.</p>\n<p>Perhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.</p>\n<p>In further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.</p>\n<p>A weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.</p>\n<p>This slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.</p>\n<p>Last week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.</p>\n<p>The second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.</p>\n<p>When this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is <a href=\"https://laohu8.com/S/AONE.U\">one</a> possible solution, but availability may be limited in most parts of the world.</p>\n<p>On the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.</p>\n<p>\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.</p>\n<p>Meanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.</p>\n<p>\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market&nbsp;commentary&nbsp;on Monday.</p>\n<p>Recent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer’s FDA Approval Has Been A Boon For Oil Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 09:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html><strong>Oilprice.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162038191","content_text":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.\nPerhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.\nIn further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.\nA weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.\nThis slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.\nLast week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.\nThe second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.\nWhen this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is one possible solution, but availability may be limited in most parts of the world.\nOn the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.\n\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.\nMeanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.\n\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market commentary on Monday.\nRecent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5640011,"gmtCreate":1629855814137,"gmtModify":1635143180734,"authorId":3571345352614779,"author":{"id":3571345352614779,"authorId":3571345352614779,"name":"小白添祥","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":837302465,"type":1,"supId":0,"prevId":0,"content":"like &amp; comment please, thank you very much ","text":"like &amp; comment please, thank you very much ","html":"like &amp; comment please, thank you very much "}],"langContent":"EN"},{"id":837309961,"gmtCreate":1629855177853,"gmtModify":1631884085329,"author":{"id":"3582251063635557","authorId":"3582251063635557","authorIdStr":"3582251063635557","name":"关耳火丙光军","avatar":"https://static.tigerbbs.com/7297dbb98183fa4daf629f4a49f6de07","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582251063635557"},"htmlText":"Share of Pfizer will shoot up further...........! Buy","listText":"Share of Pfizer will shoot up further...........! Buy","text":"Share of Pfizer will shoot up further...........! Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/837309961","repostId":2162038191,"repostType":4,"repost":{"id":"2162038191","pubTimestamp":1629853500,"share":"https://www.laohu8.com/m/news/2162038191?lang=&edition=full","pubTime":"2021-08-25 09:05","market":"us","language":"en","title":"Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2162038191","media":"Oilprice.com","summary":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in o","content":"<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.</p>\n<p>Perhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.</p>\n<p>In further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.</p>\n<p>A weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.</p>\n<p>This slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.</p>\n<p>Last week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.</p>\n<p>The second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.</p>\n<p>When this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is <a href=\"https://laohu8.com/S/AONE.U\">one</a> possible solution, but availability may be limited in most parts of the world.</p>\n<p>On the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.</p>\n<p>\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.</p>\n<p>Meanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.</p>\n<p>\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market&nbsp;commentary&nbsp;on Monday.</p>\n<p>Recent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer’s FDA Approval Has Been A Boon For Oil Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 09:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html><strong>Oilprice.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162038191","content_text":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.\nPerhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.\nIn further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.\nA weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.\nThis slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.\nLast week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.\nThe second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.\nWhen this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is one possible solution, but availability may be limited in most parts of the world.\nOn the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.\n\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.\nMeanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.\n\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market commentary on Monday.\nRecent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5640013,"gmtCreate":1629855822059,"gmtModify":1635143180516,"authorId":3571345352614779,"author":{"id":3571345352614779,"authorId":3571345352614779,"name":"小白添祥","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":837309961,"type":1,"supId":0,"prevId":0,"content":"like &amp; comment please, thank you very much ","text":"like &amp; comment please, thank you very much ","html":"like &amp; comment please, thank you very much "},{"id":5640105,"gmtCreate":1629856298052,"gmtModify":1635143172826,"authorId":3586134096690696,"author":{"id":3586134096690696,"authorId":3586134096690696,"name":"500k","avatar":"https://static.tigerbbs.com/fd86cc55cfd328a8cc3e07107ac8f108","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":837309961,"type":1,"supId":0,"prevId":0,"content":"why approved share price down ??","text":"why approved share price down ??","html":"why approved share price down ??"}],"langContent":"EN"},{"id":837971439,"gmtCreate":1629854919721,"gmtModify":1633681937431,"author":{"id":"3586650352963687","authorId":"3586650352963687","authorIdStr":"3586650352963687","name":"Eatmi","avatar":"https://static.tigerbbs.com/c87cf272101a80f24fca3ccaf2ff53e5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586650352963687"},"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/837971439","repostId":2162038191,"repostType":4,"repost":{"id":"2162038191","pubTimestamp":1629853500,"share":"https://www.laohu8.com/m/news/2162038191?lang=&edition=full","pubTime":"2021-08-25 09:05","market":"us","language":"en","title":"Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2162038191","media":"Oilprice.com","summary":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in o","content":"<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.</p>\n<p>Perhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.</p>\n<p>In further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.</p>\n<p>A weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.</p>\n<p>This slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.</p>\n<p>Last week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.</p>\n<p>The second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.</p>\n<p>When this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is <a href=\"https://laohu8.com/S/AONE.U\">one</a> possible solution, but availability may be limited in most parts of the world.</p>\n<p>On the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.</p>\n<p>\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.</p>\n<p>Meanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.</p>\n<p>\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market&nbsp;commentary&nbsp;on Monday.</p>\n<p>Recent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer’s FDA Approval Has Been A Boon For Oil Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 09:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html><strong>Oilprice.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162038191","content_text":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.\nPerhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.\nIn further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.\nA weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.\nThis slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.\nLast week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.\nThe second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.\nWhen this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is one possible solution, but availability may be limited in most parts of the world.\nOn the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.\n\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.\nMeanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.\n\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market commentary on Monday.\nRecent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5640015,"gmtCreate":1629855830874,"gmtModify":1635143180298,"authorId":3571345352614779,"author":{"id":3571345352614779,"authorId":3571345352614779,"name":"小白添祥","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":837971439,"type":1,"supId":0,"prevId":0,"content":"like &amp; comment please, thank you very much ","text":"like &amp; comment please, thank you very much ","html":"like &amp; comment please, thank you very much "}],"langContent":"EN"},{"id":837947699,"gmtCreate":1629854720711,"gmtModify":1633681940936,"author":{"id":"3571482211918385","authorId":"3571482211918385","authorIdStr":"3571482211918385","name":"KTX","avatar":"https://static.tigerbbs.com/f7d2d6c9788fbae7ed024ed5ba7c58e4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3571482211918385"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/837947699","repostId":2162038191,"repostType":4,"repost":{"id":"2162038191","pubTimestamp":1629853500,"share":"https://www.laohu8.com/m/news/2162038191?lang=&edition=full","pubTime":"2021-08-25 09:05","market":"us","language":"en","title":"Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2162038191","media":"Oilprice.com","summary":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in o","content":"<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.</p>\n<p>Perhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.</p>\n<p>In further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.</p>\n<p>A weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.</p>\n<p>This slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.</p>\n<p>Last week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.</p>\n<p>The second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.</p>\n<p>When this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is <a href=\"https://laohu8.com/S/AONE.U\">one</a> possible solution, but availability may be limited in most parts of the world.</p>\n<p>On the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.</p>\n<p>\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.</p>\n<p>Meanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.</p>\n<p>\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market&nbsp;commentary&nbsp;on Monday.</p>\n<p>Recent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer’s FDA Approval Has Been A Boon For Oil Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 09:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html><strong>Oilprice.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162038191","content_text":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.\nPerhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.\nIn further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.\nA weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.\nThis slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.\nLast week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.\nThe second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.\nWhen this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is one possible solution, but availability may be limited in most parts of the world.\nOn the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.\n\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.\nMeanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.\n\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market commentary on Monday.\nRecent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":837942255,"gmtCreate":1629854576477,"gmtModify":1633681943355,"author":{"id":"3582714812293607","authorId":"3582714812293607","authorIdStr":"3582714812293607","name":"Darylzhuo","avatar":"https://static.tigerbbs.com/fd5e4be85ccfbeb4c1c4b4faed74f6f1","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3582714812293607"},"htmlText":"Please like and comment. Thank you&nbsp;","listText":"Please like and comment. Thank you&nbsp;","text":"Please like and comment. Thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/837942255","repostId":2162038191,"repostType":4,"repost":{"id":"2162038191","pubTimestamp":1629853500,"share":"https://www.laohu8.com/m/news/2162038191?lang=&edition=full","pubTime":"2021-08-25 09:05","market":"us","language":"en","title":"Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2162038191","media":"Oilprice.com","summary":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in o","content":"<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.</p>\n<p>Perhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.</p>\n<p>In further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.</p>\n<p>A weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.</p>\n<p>This slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.</p>\n<p>Last week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.</p>\n<p>The second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.</p>\n<p>When this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is <a href=\"https://laohu8.com/S/AONE.U\">one</a> possible solution, but availability may be limited in most parts of the world.</p>\n<p>On the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.</p>\n<p>\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.</p>\n<p>Meanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.</p>\n<p>\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market&nbsp;commentary&nbsp;on Monday.</p>\n<p>Recent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer’s FDA Approval Has Been A Boon For Oil Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 09:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html><strong>Oilprice.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162038191","content_text":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.\nPerhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.\nIn further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.\nA weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.\nThis slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.\nLast week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.\nThe second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.\nWhen this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is one possible solution, but availability may be limited in most parts of the world.\nOn the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.\n\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.\nMeanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.\n\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market commentary on Monday.\nRecent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5639828,"gmtCreate":1629854950353,"gmtModify":1635143197123,"authorId":3586650352963687,"author":{"id":3586650352963687,"authorId":3586650352963687,"name":"Eatmi","avatar":"https://static.tigerbbs.com/c87cf272101a80f24fca3ccaf2ff53e5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":837942255,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"EN"},{"id":837954042,"gmtCreate":1629854167986,"gmtModify":1633681949990,"author":{"id":"4088815138354210","authorId":"4088815138354210","authorIdStr":"4088815138354210","name":"Al3x","avatar":"https://static.tigerbbs.com/76537eea7f5e56814a3866c383a688d2","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4088815138354210"},"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/837954042","repostId":2162038191,"repostType":4,"repost":{"id":"2162038191","pubTimestamp":1629853500,"share":"https://www.laohu8.com/m/news/2162038191?lang=&edition=full","pubTime":"2021-08-25 09:05","market":"us","language":"en","title":"Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2162038191","media":"Oilprice.com","summary":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in o","content":"<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.</p>\n<p>Perhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.</p>\n<p>In further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.</p>\n<p>A weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.</p>\n<p>This slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.</p>\n<p>Last week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.</p>\n<p>The second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.</p>\n<p>When this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is <a href=\"https://laohu8.com/S/AONE.U\">one</a> possible solution, but availability may be limited in most parts of the world.</p>\n<p>On the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.</p>\n<p>\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.</p>\n<p>Meanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.</p>\n<p>\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market&nbsp;commentary&nbsp;on Monday.</p>\n<p>Recent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer’s FDA Approval Has Been A Boon For Oil Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 09:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html><strong>Oilprice.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162038191","content_text":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.\nPerhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.\nIn further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.\nA weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.\nThis slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.\nLast week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.\nThe second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.\nWhen this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is one possible solution, but availability may be limited in most parts of the world.\nOn the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.\n\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.\nMeanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.\n\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market commentary on Monday.\nRecent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5639679,"gmtCreate":1629854190273,"gmtModify":1635143210168,"authorId":3559879974026501,"author":{"id":3559879974026501,"authorId":3559879974026501,"name":"豪仔9","avatar":"https://static.tigerbbs.com/16a74a110a29b4de40f0f8151e81dd87","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":837954042,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"}],"langContent":"EN"},{"id":837952767,"gmtCreate":1629854107259,"gmtModify":1633681951031,"author":{"id":"3582151718585472","authorId":"3582151718585472","authorIdStr":"3582151718585472","name":"FrederickL","avatar":"https://static.tigerbbs.com/21ae0da315b7fd514ea9d30bfa0d125a","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3582151718585472"},"htmlText":"Becos the material requirements to make it? 🤔","listText":"Becos the material requirements to make it? 🤔","text":"Becos the material requirements to make it? 🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/837952767","repostId":2162038191,"repostType":4,"repost":{"id":"2162038191","pubTimestamp":1629853500,"share":"https://www.laohu8.com/m/news/2162038191?lang=&edition=full","pubTime":"2021-08-25 09:05","market":"us","language":"en","title":"Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2162038191","media":"Oilprice.com","summary":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in o","content":"<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.</p>\n<p>Perhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.</p>\n<p>In further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.</p>\n<p>A weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.</p>\n<p>This slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.</p>\n<p>Last week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.</p>\n<p>The second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.</p>\n<p>When this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is <a href=\"https://laohu8.com/S/AONE.U\">one</a> possible solution, but availability may be limited in most parts of the world.</p>\n<p>On the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.</p>\n<p>\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.</p>\n<p>Meanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.</p>\n<p>\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market&nbsp;commentary&nbsp;on Monday.</p>\n<p>Recent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer’s FDA Approval Has Been A Boon For Oil Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 09:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html><strong>Oilprice.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162038191","content_text":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.\nPerhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.\nIn further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.\nA weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.\nThis slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.\nLast week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.\nThe second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.\nWhen this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is one possible solution, but availability may be limited in most parts of the world.\nOn the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.\n\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.\nMeanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.\n\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market commentary on Monday.\nRecent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":837956310,"gmtCreate":1629854067230,"gmtModify":1633681952134,"author":{"id":"4090385848895520","authorId":"4090385848895520","authorIdStr":"4090385848895520","name":"5949571c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4090385848895520"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/837956310","repostId":2162038191,"repostType":4,"repost":{"id":"2162038191","pubTimestamp":1629853500,"share":"https://www.laohu8.com/m/news/2162038191?lang=&edition=full","pubTime":"2021-08-25 09:05","market":"us","language":"en","title":"Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2162038191","media":"Oilprice.com","summary":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in o","content":"<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.</p>\n<p>Perhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.</p>\n<p>In further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.</p>\n<p>A weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.</p>\n<p>This slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.</p>\n<p>Last week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.</p>\n<p>The second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.</p>\n<p>When this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is <a href=\"https://laohu8.com/S/AONE.U\">one</a> possible solution, but availability may be limited in most parts of the world.</p>\n<p>On the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.</p>\n<p>\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.</p>\n<p>Meanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.</p>\n<p>\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market&nbsp;commentary&nbsp;on Monday.</p>\n<p>Recent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer’s FDA Approval Has Been A Boon For Oil Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 09:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html><strong>Oilprice.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162038191","content_text":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.\nPerhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.\nIn further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.\nA weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.\nThis slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.\nLast week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.\nThe second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.\nWhen this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is one possible solution, but availability may be limited in most parts of the world.\nOn the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.\n\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.\nMeanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.\n\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market commentary on Monday.\nRecent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5639674,"gmtCreate":1629854177024,"gmtModify":1631894105537,"authorId":4088815138354210,"author":{"id":4088815138354210,"authorId":4088815138354210,"name":"Al3x","avatar":"https://static.tigerbbs.com/76537eea7f5e56814a3866c383a688d2","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":837956310,"type":1,"supId":0,"prevId":0,"content":"like","text":"like","html":"like"}],"langContent":"EN"},{"id":837958548,"gmtCreate":1629854027084,"gmtModify":1631891963036,"author":{"id":"3574686466924712","authorId":"3574686466924712","authorIdStr":"3574686466924712","name":"Ignis","avatar":"https://static.tigerbbs.com/543d1f3e8b4901fba226eb61e5713bc4","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3574686466924712"},"htmlText":"Dotn know don't care","listText":"Dotn know don't care","text":"Dotn know don't care","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/837958548","repostId":2162038191,"repostType":4,"repost":{"id":"2162038191","pubTimestamp":1629853500,"share":"https://www.laohu8.com/m/news/2162038191?lang=&edition=full","pubTime":"2021-08-25 09:05","market":"us","language":"en","title":"Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2162038191","media":"Oilprice.com","summary":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in o","content":"<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.</p>\n<p>Perhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.</p>\n<p>In further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.</p>\n<p>A weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.</p>\n<p>This slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.</p>\n<p>Last week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.</p>\n<p>The second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.</p>\n<p>When this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is <a href=\"https://laohu8.com/S/AONE.U\">one</a> possible solution, but availability may be limited in most parts of the world.</p>\n<p>On the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.</p>\n<p>\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.</p>\n<p>Meanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.</p>\n<p>\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market&nbsp;commentary&nbsp;on Monday.</p>\n<p>Recent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer’s FDA Approval Has Been A Boon For Oil Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer’s FDA Approval Has Been A Boon For Oil Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 09:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html><strong>Oilprice.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/why-pfizer-fda-approval-boon-230000462.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2162038191","content_text":"The recent resurgence in Covid-19 infections in many parts of the world led not just to a slump in oil prices but growing pessimism about the prospects of oil demand. However, some recent news has reversed the sentiment, with optimism pushing prices higher again.\nPerhaps the biggest news was the Food and Drug Administration's granting full approval of the Pfizer/BioNTech vaccine this week. The approval sparked hopes that vaccine hesitancy in the United States would diminish now, which would in turn potentially encourage more fuel demand.\nIn further good news for oil, China reported zero new Covid-19 cases this week after clamping down on several local outbreaks. As the world's largest oil importer, China is a weathervane for oil prices, and this week, the weathervane is pointing towards more oil demand.\nA weaker U.S. dollar contributed to the positive sentiment as it is usually conducive to stronger oil demand, as did reports of higher refinery throughputs in India in July. These rose by close to 10 percent on the year and were accompanied by an increase in fuel demand in the country by the most since April.\nThis slew of bullish news for oil might lead to a change in the behavior of large oil traders such as hedge funds, which have continued selling oil futures for seven of the last nine weeks now, according to the latest weekly column on oil buying and selling by Reuters' John Kemp.\nLast week hedge funds and other institutional traders sold the equivalent of some 25 million barrels of Brent and 9 million barrels of West Texas Intermediate. Reuters' market analyst noted that most of the sales were profit-taking, but about 12 million barrels were \"new bearish short-selling\" in anticipation of weaker fundamentals for oil in the second quarter. Since June 15, traders have sold a total 253 million barrels of oil.\nThe second-half outlook for oil demand remains mired in uncertainty. Despite rising levels of vaccination in Europe and the United States, analyst expectations about the lifting of all travel restrictions appear to be guarded. Per Reuters' Kemp, most governments will likely also take the guarded path and not rush into lifting restrictions on international movement until there is a fair degree of certainty that the spread of the coronavirus is under control.\nWhen this degree of certainty will be achieved remains to be seen as reports begin to come in about rising numbers of breakthrough Covid-19 infections in vaccinated people. The addition of booster shots is one possible solution, but availability may be limited in most parts of the world.\nOn the flip side, as a growing number of U.S. companies are beginning to mandate vaccines for their employees, some analysts expect a strong rebound in work-related travel in the fall.\n\"With many corporations and government agencies likely to enforce vaccine mandates, return to office travel should dramatically pick up in the fall,\" OANDA analyst Edward Moya told Reuters this week.\nMeanwhile, many will be watching this week's Fed meeting, which could produce updates on the central bank's plans to start winding down its stimulus program.\n\"While the virus remains a threat to the short-term demand outlook, despite signs of an improving situation in China, this week's Jackson Hole summit may give the market some ideas about the timing of tapering,\" Saxo Bank said in a market commentary on Monday.\nRecent comments from senior Fed officials that tapering needs to start sooner rather than later because the economy is growing strongly have contributed to oil's decline. This means that any news to the effect of tapering likely to happen later rather than sooner would be bullish for prices. The chance of this has recently increased with the number of Covid-19 infections.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5639639,"gmtCreate":1629854059500,"gmtModify":1631891963038,"authorId":4090385848895520,"author":{"id":4090385848895520,"authorId":4090385848895520,"name":"5949571c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":837958548,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":190,"commentSize":17,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false}}